Aleafia Health (AH.TO) Osake Kurssi
Aleafia Health Kurssi
Viimeisten 7 vuoden aikana Aleafia Healthn liikevaihto kasvoi 54,1 % vuodessa ja ylsi 42,85 M CAD:een. Aleafia Healthn nettomarginaali −80,8 % on noussut verrattuna −242,2 %:iin muutama vuosi sitten.
Aleafia Health osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Aleafia Health liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Aleafia Health -osakkeesta
The business model of Aleafia Health Inc. revolves around the provision of medical cannabis products, services, and education. As a leading Canadian cannabis company, Aleafia Health focuses on vertically integrating its operations, spanning the entire cannabis value chain. By cultivating high-quality cannabis strains, the company ensures a consistent supply of medical-grade cannabis. Aleafia Health operates medical cannabis clinics where patients receive personalized treatment plans and have access to a wide range of cannabis products. Through its education and training initiatives, Aleafia Health aims to enhance understanding and awareness of medical cannabis among healthcare practitioners.
Aleafia Health Inc is primarily active in the healthcare and cannabis industry.
The main competitors of Aleafia Health Inc in the market include Canopy Growth Corporation, Aurora Cannabis Inc, and Cronos Group Inc.
Aleafia Health Inc is a leading Canadian cannabis company that specializes in producing and distributing high-quality medical cannabis products. Founded in 2007, the company has built a solid reputation for its commitment to patient care and providing innovative treatment options. With its headquarters in Concord, Ontario, Aleafia Health operates a network of medical cannabis clinics across Canada. The company focuses on both cultivation and research to develop effective cannabis strains for various medical conditions. Aleafia Health is dedicated to advancing the science and understanding of cannabis and its therapeutic benefits, offering patients a reliable and trusted source for their medical cannabis needs.
Aleafia Health Inc. has achieved several significant milestones since its establishment. Notably, the company expanded its production capacity by acquiring the Niagara Greenhouse facility. Moreover, Aleafia Health Inc. successfully launched its medical cannabis clinic network, which has rapidly grown to become one of the largest nationwide. Additionally, the company entered into a strategic partnership with Emblem Corp. to establish a leading Canadian medical cannabis brand. Furthermore, Aleafia Health Inc. was listed on the Toronto Stock Exchange in 2018, demonstrating its commitment to providing value to its shareholders. These milestones reflect Aleafia Health Inc.'s dedication towards growth, innovation, and becoming a reputable player in the cannabis industry.
Aleafia Health Inc is primarily present in Canada.
Aleafia Health Inc represents a commitment to providing quality healthcare solutions and improving the well-being of patients. The company follows a patient-centric approach, placing great emphasis on holistic care and personalized treatment options. Aleafia Health Inc focuses on creating innovative medical cannabis therapies, supported by cutting-edge research and development. With a strong dedication to advancing the medical cannabis industry, Aleafia Health Inc aims to provide accessible and high-quality healthcare products for patients worldwide. The company's corporate philosophy revolves around transparency, integrity, and collaboration to foster a nurturing and supportive environment for patients and stakeholders.
8 analyytikkoa arvioi tällä hetkellä Aleafia Health-osaketta: 0 suosittaa ostoa, 3 pitoa ja 5 myyntiä.
Aleafia Health-osake (AH.TO) on listattuna 6 pörssissä, muun muassa: Toronto (AH.TO), Frankfurt (ARAH.F), München (ARAH.MU), Düsseldorf (ARAH.DU), Hamburg (ARAH.HM).
Aleafia Health Inc is a Canadian company that operates in the cannabis industry. Its business model is focused on providing high-quality medical cannabis products and services. One key aspect is the vertical integration model, which means that the company operates from cultivation to sales of cannabis products. One of the main suppliers, Aleafia Farms, has a cultivation area of approximately 22 hectares. The plants are grown optimally and include the production of dry herb and oil extraction. The focus is on producing medical products to improve patient health. The company exclusively works with organically grown and sustainable cannabis. Another part of the business model is providing healthcare services and products to patients in need of medical cannabis treatment. Aleafia Health offers everything from clinical services to developing online platforms for medical diagnostics. The company has a team of medical professionals who examine patients, analyze medical data, and provide recommendations for dosing cannabis products. The products sold include pills, oils, tinctures, and lozenges, with various dosing methods depending on the individual patient's needs. Aleafia's main goal is to improve patient health and support modern medicine through the use of cannabis products. They reduce pain perception, improve symptoms of PTSD and ADD, and enhance appetite and nausea stimulation in patients. Customers of Aleafia Health Inc have access to a wide range of top-quality medical products and services. The company aims to increase its reach and product benefits through partnerships with other healthcare organizations. In conclusion, Aleafia Health Inc's business model is focused on producing high-quality medical cannabis products and providing top-notch healthcare services. The company operates one of the most comprehensive vertically integrated cannabis supply chains in Canada and emphasizes the use of quality, organically grown plants. They offer customers a wide range of products and services with various dosing methods and collaborate closely with healthcare specialists to achieve the best therapeutic outcomes for patients. Aleafia Health strives to strengthen its position as a leading company in the medical cannabis industry.
Liikevaihtoa ei voida laskea Aleafia Health:lle tällä hetkellä.
Voittoa ei voida laskea Aleafia Health:lle tällä hetkellä.
P/E-suhdetta ei voida laskea Aleafia Health:lle tällä hetkellä.
P/S-suhdetta ei voida laskea Aleafia Health:lle tällä hetkellä.
Aleafia Health:n Eulpool-laatuscore on 4/10.
Aleafia Health:n ISIN on CA01444Q1046. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Aleafia Health:n WKN on A2JHC5. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Aleafia Health:n ticker on AH.TO. Tämä pörssinoteeraus käytetään Aleafia Health-osakkeiden kauppaan pörssissä.
Aleafia Health osake
Aleafia Health vertaisryhmä
Aleafia Health Ticker
Aleafia Health FIGI
Kaikki tunnusluvut ja syvällinen analyysi Aleafia Health:sta
Meidän osakeanalyysimme Aleafia Health-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Aleafia Health:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: